Jordan, represented by the Jordan Food and Drug Administration (JFDA), has been granted full membership in the Pharmaceutical Inspection Co-operation Scheme (PIC/S), becoming the second Arab nation to ...

MediWound Successfully Completes Commissioning of Expanded GMP Manufacturing Facility for NexoBrid® Newly commissioned facility marks a significant development toward a sixfold production capacity ...

Indian stocks were little changed at the end of the first trading day of November on Monday, with investors taking a breather ...

President Trump wants pharmaceutical production to return to the United States. A shuttered factory in Louisiana shows how ...

George Tidmarsh, the newly installed director of the FDA’s Center for Drug Evaluation and Research, was placed on leave ...

Developers of biosimilars, medicines that are near-identical copies of biologic drugs, will no longer be required to conduct clinical trials to prove effectiveness.

Dr. George Tidmarsh had been placed on leave Friday after Health and Human Services officials were notified of the issues, a ...

Having seen Congress spend money to onshore semiconductor production, pharma groups are pushing for similar incentives for ...

The director of the U.S. Food and Drug Administration's Center for Drug Evaluation and Research, George Tidmarsh, resigned on Sunday amid serious concerns about his personal conduct, a Department of ...

FDA recently issued the draft guidance, Quality Management System Information for Certain Premarket Submission Reviews. The guidance is designed ...

Bharat Biotech is venturing into advanced therapies by launching Nucelion Therapeutics, a subsidiary focused on cell and gene therapies. This new enti ...